Source: International Congress 2016 – Basic science and case reports in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Kuo-Liang Chiu (Taichung, Taiwan), Kuo-Liang Chiu, Ting-Ting Kuo, Qian-Yu Kuok, Liang-Chuan Lai, Yuh-Pyng Sher. ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumour metastasis. Eur Respir J 2016; 48: Suppl. 60, 2842

Member's Comments

No comment yet.

Related content which might interest you: IL-17C promotes tumor-associated inflammation and lung tumor growth Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 Correlation of miR-422a, miR-21 and miR-155 analysis with hMSH2 and hMLH1 mRNA expression profiles in non-small cell lung carcinomas and their adjacent normal tissues Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2 Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Prognostic significance of the expressions of Axl and/or Gas6 in patients with completely resected lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Downregulated anti-angiogenic miR-19a, miR-126 and let-7b in non-small lung cancer have poor but different prognostic values in squamous and adenocarcinoma subtypes Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 beta-F1-ATPase expression as a prognostic factor for resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Overexpression of LincR-PICALM promotes lung cancer proliferation and metastasis by miR-199a-3p suppression and cis- regulation Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019 Prognostic value and functional characterization of miR-141 and miR-200c expression levels in resected NSCL Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 The roles of Ki-67, p53, transforming growth factor- and lysyl oxidase in the metastasis of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Prognostic value of p21 protein expression in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Simvastatin overcomes gefitinib resistance in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor via Akt/b-catenin signaling dependent down-regulation of survivin Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC) Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 p53 and mdm2 expression in nonsmall cell lung cancer (NSCLC): the lack of prognostic relevance Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 The prognostic value of altered pRb and p53 protein expression in non-small cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 363s Year: 2003